359 667

Cited 38 times in

In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea

DC Field Value Language
dc.contributor.author김창기-
dc.contributor.author염종화-
dc.contributor.author용동은-
dc.contributor.author이경원-
dc.contributor.author정윤섭-
dc.date.accessioned2014-12-21T16:24:40Z-
dc.date.available2014-12-21T16:24:40Z-
dc.date.issued2007-
dc.identifier.issn0066-4804-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/95641-
dc.description.abstractThe in vitro activities of CG400549, a novel FabI inhibitor, were compared to those of linezolid and commonly used antimicrobials against recent bacterial isolates. CG400549 had an MIC(90) of 0.5 microg/ml for Staphylococcus aureus strains and was more potent than either linezolid or vancomycin.-
dc.description.statementOfResponsibilityopen-
dc.format.extent2591~2593-
dc.relation.isPartOfANTIMICROBIAL AGENTS AND CHEMOTHERAPY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleIn vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Laboratory Medicine (진단검사의학)-
dc.contributor.googleauthorJong Hwa Yum-
dc.contributor.googleauthorChang Ki Kim-
dc.contributor.googleauthorJoong Myung Cho-
dc.contributor.googleauthorSeonggu Ro-
dc.contributor.googleauthorJeong Mi Kim-
dc.contributor.googleauthorCheol Min Kim-
dc.contributor.googleauthorYunsop Chong-
dc.contributor.googleauthorKyungwon Lee-
dc.contributor.googleauthorDongeun Yong-
dc.identifier.doi10.1128/AAC.01562-06-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA01038-
dc.contributor.localIdA02352-
dc.contributor.localIdA02423-
dc.contributor.localIdA02649-
dc.contributor.localIdA03679-
dc.relation.journalcodeJ00189-
dc.identifier.eissn1098-6596-
dc.contributor.alternativeNameKim, Chang Ki-
dc.contributor.alternativeNameYum, Jong Hwa-
dc.contributor.alternativeNameYong, Dong Eun-
dc.contributor.alternativeNameLee, Kyung Won-
dc.contributor.alternativeNameChong, Yun Sop-
dc.contributor.affiliatedAuthorKim, Chang Ki-
dc.contributor.affiliatedAuthorYum, Jong Hwa-
dc.contributor.affiliatedAuthorYong, Dong Eun-
dc.contributor.affiliatedAuthorLee, Kyung Won-
dc.contributor.affiliatedAuthorChong, Yun Sop-
dc.rights.accessRightsfree-
dc.citation.volume51-
dc.citation.number7-
dc.citation.startPage2591-
dc.citation.endPage2593-
dc.identifier.bibliographicCitationANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Vol.51(7) : 2591-2593, 2007-
dc.identifier.rimsid44986-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Laboratory Medicine (진단검사의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.